Insider Buying: Anteris Technologies Global (NASDAQ:AVR) Major Shareholder Buys $4,869,897.05 in Stock

Key Points

• L1 Capital significantly increased its Anteris Technologies Global stake, purchasing 648,455 shares for approximately $4.87 million at an average price of $7.51. The transaction raised its direct holdings by 5.35% to 12.78 million shares, worth about $96 million.
• AVR shares opened at $7.55, with a market capitalization of approximately $735.8 million and a 52-week range of $3.30 to $11.06. The company recently reported a quarterly loss of $0.30 per share and revenue of $1.01 million, both below analyst expectations.
• Analyst sentiment remains mixed but generally favorable: four analysts rate the stock Buy and one rates it Sell, producing a “Moderate Buy” consensus and an average price target of $16.00.

Anteris Technologies Global Corp. (NASDAQ:AVR - Get Free Report) major shareholder L1 Capital Pty Ltd acquired 648,455 shares of the firm's stock in a transaction on Monday, October 5th. The shares were acquired at an average price of $7.51 per share, with a total value of $4,869,897.05. Following the completion of the transaction, the insider directly owned 12,778,380 shares in the company, valued at approximately $95,965,633.80. This trade represents a 5.35% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.

L1 Capital Pty Ltd also recently made the following trade(s):

• On Friday, October 2nd, L1 Capital Pty Ltd acquired 236,354 shares of Anteris Technologies Global stock. The stock was bought at an average price of $7.78 per share, for a total transaction of $1,838,834.12.
• On Thursday, October 1st, L1 Capital Pty Ltd bought 322,940 shares of Anteris Technologies Global stock. The stock was bought at an average price of $7.60 per share, with a total value of $2,454,344.00.
• On Wednesday, September 30th, L1 Capital Pty Ltd bought 74,286 shares of Anteris Technologies Global stock. The shares were bought at an average cost of $7.72 per share, with a total value of $573,487.92.
• On Friday, August 28th, L1 Capital Pty Ltd sold 7,800 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.83, for a total transaction of $68,874.00.
• On Tuesday, August 11th, L1 Capital Pty Ltd sold 375,815 shares of Anteris Technologies Global stock. The stock was sold at an average price of $9.30, for a total transaction of $3,495,079.50.
• On Monday, August 10th, L1 Capital Pty Ltd sold 251,844 shares of Anteris Technologies Global stock. The stock was sold at an average price of $9.10, for a total value of $2,291,780.40.
• On Thursday, August 6th, L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.10, for a total value of $1,415,240.10.
• On Tuesday, August 4th, L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.30, for a total value of $3,989,046.40.
• On Wednesday, August 5th, L1 Capital Pty Ltd sold 14,581 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.23, for a total value of $120,001.63.
• On Monday, August 3rd, L1 Capital Pty Ltd sold 475,693 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.10, for a total value of $3,853,113.30.

Anteris Technologies Global Price Performance

Shares of Anteris Technologies Global stock opened at $7.55 on Tuesday. The firm has a market cap of $735.82 million, a price-to-earnings ratio of -3.87 and a beta of 1.87. Anteris Technologies Global Corp. has a 52-week low of $3.30 and a 52-week high of $11.06. The stock has a 50-day simple moving average of $8.48 and a 200-day simple moving average of $8.00.

Anteris Technologies Global (NASDAQ:AVR - Get Free Report) last released its quarterly earnings data on Tuesday, August 11th. The company reported ($0.30) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.09). The firm had revenue of $1.01 million during the quarter, compared to analyst estimates of $1.50 million. Anteris Technologies Global had a negative return on equity of 77.69% and a negative net margin of 4,619.27%.During the same quarter in the prior year, the company posted ($0.58) EPS. As a group, equities research analysts predict that Anteris Technologies Global Corp. will post -1.21 earnings per share for the current year.

Hedge Funds Weigh In On Anteris Technologies Global

A number of institutional investors have recently made changes to their positions in the business. Nantahala Capital Management LLC bought a new stake in Anteris Technologies Global during the 2nd quarter valued at approximately $33,325,850. One68 Global Capital LLC bought a new stake in shares of Anteris Technologies Global in the second quarter valued at approximately $128,000. Bank of America Corp DE acquired a new stake in shares of Anteris Technologies Global in the second quarter worth $1,907,000. AWM Investment Company Inc. bought a new position in Anteris Technologies Global during the second quarter worth $1,133,000. Finally, ADAR1 Capital Management LLC acquired a new position in Anteris Technologies Global during the 2nd quarter valued at $30,979,000.

Analyst Ratings Changes

AVR has been the topic of several recent research reports. Cantor Fitzgerald restated an "overweight" rating and set a $15.00 target price on shares of Anteris Technologies Global in a report on Friday, August 14th. Weiss Ratings reissued a "sell (d-)" rating on shares of Anteris Technologies Global in a research note on Wednesday, August 26th. Four investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $16.00.

Anteris Technologies Global Company Profile

Anteris Technologies Global is a clinical-stage structural heart company developing technologies intended to treat aortic valve disease. The company's lead product is the DurAVR transcatheter heart valve, which is designed to replicate the performance characteristics of a healthy human aortic valve and restore more natural blood flow.

Anteris uses its proprietary ADAPT tissue-engineering technology to create heart-valve materials designed for durability and biocompatibility. The company is focused primarily on transcatheter aortic valve replacement and related structural-heart applications, with its products progressing through clinical development and regulatory evaluation rather than broad commercial distribution.

The company has Australian origins and maintains operations and clinical-development activities in both Australia and the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.